Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
MicroRNAs (miRNAs) are short (18–25 nt), non-coding, widely conserved RNA molecules responsible for regulating gene expression via sequence-specific post-transcriptional mechanisms. Since the human miRNA transcriptome regulates the expression of a number of tumor suppressors and oncogenes, its dysre...
Main Authors: | Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, Padmavati Sahare, Surajit Pathak, Antara Banerjee, Asim K. Duttaroy, Sujay Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1208547/full |
Similar Items
-
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
by: Luis Alberto Bravo-Vázquez, et al.
Published: (2023-01-01) -
miRNA interplay: Mechanisms and therapeutic interventions in cancer
by: Zehua Wang, et al.
Published: (2024-12-01) -
Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine
by: Luis Germán Castañón-Cortés, et al.
Published: (2024-10-01) -
MiRNA-based therapeutic potential in multiple sclerosis
by: Ana Zabalza, et al.
Published: (2024-08-01) -
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
by: Jun Sheng Wong, et al.
Published: (2020-07-01)